Peptides is a world leader in anti-aging technologies, peptide and non-peptide bioregulation. The company operates on the basis of the St. Petersburg Institute of Bioregulation and Gerontology. To date, products are represented in many countries of the world, more than 600 representative offices have been opened. In the arsenal of more than 300 drugs that have no analogues, both in Russia and abroad. The priority direction of the company's work is research and development in the field of aging prevention and biorevitalization programs.